Dec. 18, 2020—Moderna, remdesivir, AstraZeneca. VUMC’s experts have played an integral role in the development of these marquee COVID-19 therapeutics behind the scenes.
Cortez named interim chair in the Department of Biochemistry; York named Impossible Foods chief science officer
Dec. 8, 2020—David Cortez, Richard N. Armstrong Chair for Innovation in Biochemistry and professor of biochemistry, has been named interim chair in the Department of Biochemistry beginning Jan. 1. This follows the departure of John York, who was recently named chief science officer of California-based food technology startup Impossible Foods.
Nov. 11, 2020—Twenty-nine prominent faculty from across campus comprise Vanderbilt University’s latest endowed chair honorees. They include scholars working in diverse areas—from election analysis and lung cancer research to the nascent field of neurolaw, exploring the brain mechanism underlying legal decision-making.
Jun. 18, 2020—After discovering a new mechanism for DNA damage repair last year, Vanderbilt biochemists now provide direct evidence for how it works.
Oct. 3, 2019—Vanderbilt scientists have identified 593 proteins that are enriched at sites of DNA duplication and chromatin packaging of newly synthesized DNA.
Jul. 25, 2019—Investigators have discovered how a DNA repair pathway protein shields sites of damage to avoid mutations and maintain genome integrity.
Feb. 28, 2019—David Cortez and colleagues have discovered a new DNA repair mechanism.
Aug. 9, 2018—David Cortez and colleagues have found that a protein called RADX helps modulate a protein called RAD51 in order to make sure exactly the correct amount of DNA repair occurs.
Apr. 25, 2018—Postdoctoral scholar Natalie Hinkel has been named Postdoc of the Year by the Office of Postdoctoral Affairs for her exceptional scholarship. Assistant Professor of Psychology Anita Disney was honored as Mentor of the Year at the 12th annual Vanderbilt Postdoctoral Association Symposium April 12.
Nov. 20, 2017—Fifteen Vanderbilt faculty members conducting a range of biomedical and clinical research have been elected fellows of the American Association for the Advancement of Science. Six of the 15 have received funding through the university’s Trans-Institutional Programs initiative, which facilitates research and teaching collaborations across disciplines and are a core pillar of the university’s Academic Strategic Plan.
Jul. 20, 2017—Researchers at Vanderbilt University Medical Center (VUMC) have discovered a protein that may lead to a new way to prevent resistance and improve outcomes for patients whose cancers have mutations in the tumor suppressor gene BRCA2.
Nov. 17, 2016—Kamakoti “Kami” Bhat, a fifth-year graduate student in the lab of David Cortez, Ph.D., professor of Biochemistry in the School of Medicine, has achieved a “first” for Vanderbilt University.